Geming Lu

1.7k total citations
28 papers, 898 citations indexed

About

Geming Lu is a scholar working on Surgery, Genetics and Immunology. According to data from OpenAlex, Geming Lu has authored 28 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Genetics and 10 papers in Immunology. Recurrent topics in Geming Lu's work include Pancreatic function and diabetes (10 papers), Diabetes and associated disorders (9 papers) and Diabetes Management and Research (5 papers). Geming Lu is often cited by papers focused on Pancreatic function and diabetes (10 papers), Diabetes and associated disorders (9 papers) and Diabetes Management and Research (5 papers). Geming Lu collaborates with scholars based in United States, China and Georgia. Geming Lu's co-authors include Huabao Xiong, Miriam Mérad, Jerry E. Chipuk, Emmanuel L. Gautier, Jeffrey W. Pollard, Brian D. Brown, Milena Bogunovic, Andrew Chow, Julie Helft and Paul S. Frenette and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Geming Lu

25 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geming Lu United States 15 499 309 124 102 84 28 898
Amrita Nandan India 8 618 1.2× 285 0.9× 155 1.3× 74 0.7× 144 1.7× 12 946
Jenny Freitag Germany 8 647 1.3× 297 1.0× 111 0.9× 108 1.1× 146 1.7× 8 987
Laure Delavallée France 14 348 0.7× 357 1.2× 121 1.0× 54 0.5× 60 0.7× 19 798
Ya-Lan Guo China 15 311 0.6× 275 0.9× 128 1.0× 52 0.5× 84 1.0× 19 747
Shrimati Datta United States 11 314 0.6× 349 1.1× 83 0.7× 154 1.5× 89 1.1× 19 805
Guo‐Yun Chen United States 11 680 1.4× 434 1.4× 151 1.2× 44 0.4× 47 0.6× 25 1.1k
Kyuho Kang South Korea 16 554 1.1× 463 1.5× 262 2.1× 51 0.5× 153 1.8× 36 1.1k
Louise H. Cengia Australia 11 423 0.8× 530 1.7× 83 0.7× 53 0.5× 48 0.6× 11 772
Christopher Chang United States 10 588 1.2× 263 0.9× 139 1.1× 35 0.3× 95 1.1× 12 925
Jana Raynor United States 14 626 1.3× 258 0.8× 158 1.3× 45 0.4× 69 0.8× 19 938

Countries citing papers authored by Geming Lu

Since Specialization
Citations

This map shows the geographic impact of Geming Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geming Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geming Lu more than expected).

Fields of papers citing papers by Geming Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geming Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geming Lu. The network helps show where Geming Lu may publish in the future.

Co-authorship network of co-authors of Geming Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Geming Lu. A scholar is included among the top collaborators of Geming Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geming Lu. Geming Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Xiancai, Guanpeng Wang, Geming Lu, et al.. (2026). Selective disruption of RORγt-CBFβ interaction by IMU-935 prevents RORγt-dependent Th17 autoimmunity but not thymocyte development. Journal of Clinical Investigation. 136(1).
2.
Varela, Miguel A., Eunjin Oh, Jung Eun Lee, et al.. (2025). Human pancreatic α-cell heterogeneity and trajectory inference analyses reveal SMOC1 as a β-cell dedifferentiation gene. Nature Communications. 16(1). 8434–8434.
3.
Filipowska, Joanna, Peng Wang, Geming Lu, et al.. (2025). LGR4 is essential for maintaining β-cell homeostasis through suppression of RANK. Molecular Metabolism. 92. 102097–102097. 2 indexed citations
4.
Zhang, Lu, Qingqing Zhu, Jia Fu, et al.. (2024). Cholesterol 25‐Hydroxylase Protects Against Diabetic Kidney Disease by Regulating ADP Ribosylation Factor 4. Advanced Science. 11(29). e2309642–e2309642. 6 indexed citations
5.
Rosselot, Carolina, Yansui Li, Peng Wang, et al.. (2024). Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system. Science Translational Medicine. 16(755). eadg3456–eadg3456. 13 indexed citations
6.
Karaköse, Esra, Xuedi Wang, Peng Wang, et al.. (2024). Cycling alpha cells in regenerative drug-treated human pancreatic islets may serve as key beta cell progenitors. Cell Reports Medicine. 5(12). 101832–101832. 6 indexed citations
7.
Ables, Jessica L., L Israël, Olivia Wood, et al.. (2024). A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers. Journal of Psychopharmacology. 38(10). 911–923. 5 indexed citations
8.
Li, Yansui, Carolina Rosselot, Tuo Zhang, et al.. (2023). Single-nucleus RNA sequencing of human pancreatic islets identifies novel gene sets and distinguishes β-cell subpopulations with dynamic transcriptome profiles. Genome Medicine. 15(1). 30–30. 25 indexed citations
9.
Koya, Jagadish, Tong Shen, Geming Lu, et al.. (2022). FDA-Approved Excipient N, N-Dimethylacetamide Attenuates Inflammatory Bowel Disease in In Vitro and In Vivo Models. PubMed. 5(3). 499–509. 2 indexed citations
10.
Rosselot, Carolina, Sharon Baumel-Alterzon, Yansui Li, et al.. (2020). The many lives of Myc in the pancreatic β-cell. Journal of Biological Chemistry. 296. 100122–100122. 16 indexed citations
11.
Li, Qin, et al.. (2018). NLRP3 Inflammasome Activation Regulates Aged RBC Clearance. Inflammation. 41(4). 1361–1371. 8 indexed citations
12.
Cheung, Ka Lung, Fan Zhang, Anbalagan Jaganathan, et al.. (2017). Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation. Molecular Cell. 65(6). 1068–1080.e5. 101 indexed citations
13.
Peng, Liang, Hui Zhang, Feihong Xu, et al.. (2016). Reprogramming macrophage orientation by microRNA 146b targeting transcription factor IRF5. EBioMedicine. 14. 83–96. 55 indexed citations
14.
Lu, Geming, et al.. (2016). Overexpression of a glucokinase point mutant in the treatment of diabetes mellitus. Gene Therapy. 23(4). 323–329. 11 indexed citations
15.
Jayaraman, Padmini, Peter F. Svider, Falguni Parikh, et al.. (2014). iNOS Expression in CD4+ T Cells Limits Treg Induction by Repressing TGFβ1: Combined iNOS Inhibition and Treg Depletion Unmask Endogenous Antitumor Immunity. Clinical Cancer Research. 20(24). 6439–6451. 48 indexed citations
16.
17.
Zhang, Ruihua, Qin Li, Peter Y. Chuang, et al.. (2013). Regulation of Pathogenic Th17 Cell Differentiation by IL-10 in the Development of Glomerulonephritis. American Journal Of Pathology. 183(2). 402–412. 14 indexed citations
18.
Zhang, Yi, Ruihua Zhang, Huafeng Zhang, et al.. (2012). Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunity. Cellular and Molecular Immunology. 9(6). 489–496. 22 indexed citations
19.
Greter, Melanie, Julie Helft, Andrew Chow, et al.. (2012). GM-CSF Controls Nonlymphoid Tissue Dendritic Cell Homeostasis but Is Dispensable for the Differentiation of Inflammatory Dendritic Cells. Immunity. 36(6). 1031–1046. 325 indexed citations
20.
Ouyang, Xinshou, Zhuoshun Yang, Ruihua Zhang, et al.. (2010). Potentiation of Th17 cytokines in aging process contributes to the development of colitis. Cellular Immunology. 266(2). 208–217. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amrita Nandan Breakdown of academic impact, for papers by Jenny Freitag Breakdown of academic impact, for papers by Laure Delavallée Breakdown of academic impact, for papers by Ya-Lan Guo Breakdown of academic impact, for papers by Shrimati Datta Breakdown of academic impact, for papers by Guo‐Yun Chen Breakdown of academic impact, for papers by Kyuho Kang Breakdown of academic impact, for papers by Louise H. Cengia Breakdown of academic impact, for papers by Christopher Chang Breakdown of academic impact, for papers by Jana Raynor
Rankless by CCL
2026